Blake Mastin Read, MD
Colorectal Surgery (Proctology) · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · County of San Mateo
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Research they published
5 papers · cited 77 times
Published as Blake Read at Mills-Peninsula Medical Center, Sutter Health.
Research identity is not a guarantee of current clinical practice. Same name is not the same person — if this looks like someone else, tell us.
| 2020 | Aggressive Colorectal Cancer in the YoungFirst author | Clinics in Colon and Rectal Surgery |
| 2020 | Hartmann’s reversal: factors affecting complications and outcomes | International Journal of Colorectal Disease |
| 2018 | Frequency and timing of short-term complications following abdominoperineal resection | Journal of Surgical Research |
| 1988 | Diagnosis of congenital dislocated hips (CDH). | PubMed |
Topics: Colorectal Cancer Surgical Treatments · Shoulder Injury and Treatment · Colorectal Cancer Screening and Detection · Streptococcal Infections and Treatments · Hip disorders and treatments
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Read’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A126722 · Current
Licensed to practise in California · since 2013 · expires 2026-12-31 · Jefferson Medical College of Thomas Jefferson University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$106,388
Medicare paid this office $106,388 for 200 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Partial removal of large bowel and reattachment to rectum using an endoscope | 12 | $14,811 | $1,234 |
| Return visit (30+ min) | 47 | $6,270 | $114 |
| Long return visit (40+ min) | 27 | $5,656 | $162 |
| New patient visit (45+ min) | 34 | $4,792 | $141 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,614 | $154 |
See all 11 services
| Partial removal of large bowel and reattachment to rectum using an endoscope | 12 | $14,811 | $1,234 |
| Return visit (30+ min) | 47 | $6,270 | $114 |
| Long return visit (40+ min) | 27 | $5,656 | $162 |
| New patient visit (45+ min) | 34 | $4,792 | $141 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,614 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $3,788 | $105 |
| New patient visit (60+ min) | 14 | $2,901 | $207 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,726 | $114 |
| Diagnostic exam of anus with magnification and chemical agent enhancement using an endoscope | 12 | $2,000 | $143 |
| Short return visit (20+ min) | 18 | $1,846 | $80 |
| Injection of agent into vein to assess blood flow of skin graft or flap | 16 | $650 | $41 |
Procedures Medicare counted
| Colonoscopy | 12 | More than 42% of doctors who do this |
| Melanoma (skin cancer) excision | 1-10 | None |
Who their Medicare patients are
200 Original Medicare patients in 2024. Average age 77 · Women 57% · Also on Medicaid 11% · Health risk score 1.40. At or below the middle of the specialty; the typical colorectal surgery (proctology) clinician is at 1.44.
Conditions among them: High blood pressure 72% · Cancer 36% · Coronary heart disease 31% · Diabetes 24% · Atrial fibrillation 24% · Depression 24% · Chronic kidney disease 23% · Heart failure 21% · COPD 13% · Dementia 13% · Stroke 8%.
The office billed $488,833, Medicare allowed $136,603 and paid $106,388; for 520 services of 71 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 200 | 520 | 77 | 1.40 | $488,833 | $106,388 |
| 2023 | 187 | 624 | 77 | 1.45 | $415,314 | $94,457 |
| 2022 | 215 | 509 | 77 | 1.33 | $513,344 | $118,671 |
| 2021 | 165 | 418 | 77 | 1.32 | $376,790 | $87,346 |
| 2020 | 138 | 287 | 75 | 1.39 | $302,159 | $75,308 |
| 2019 | 166 | 402 | 75 | 1.45 | $311,065 | $73,869 |
| 2018 | 32 | 51 | 78 | 2.09 | $51,181 | $12,117 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Long return visit (40+ min) | 23 | $5,184 | $167 |
| Return visit (30+ min) | 41 | $4,938 | $110 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $3,863 | $117 |
| Short return visit (20+ min) | 37 | $3,690 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $3,611 | $106 |
| Removal of external hemorrhoids by rubber banding | 12 | $3,440 | $287 |
| New patient visit (60+ min) | 14 | $2,754 | $197 |
| New patient visit (45+ min) | 16 | $2,530 | $158 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,135 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,364 | $72 |
| New patient visit (30+ min) | 11 | $1,070 | $97 |
| Injection of agent into vein to assess blood flow of skin graft or flap | 16 | $631 | $39 |
2022: 11 services
| Return visit (30+ min) | 62 | $8,267 | $115 |
| Removal of external hemorrhoids by rubber banding | 18 | $6,484 | $282 |
| New patient visit (45+ min) | 45 | $6,430 | $143 |
| Long return visit (40+ min) | 21 | $4,243 | $157 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,735 | $120 |
| New patient visit (60+ min) | 19 | $3,616 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $3,210 | $92 |
| Short return visit (20+ min) | 31 | $2,899 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,098 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,947 | $177 |
| Injection of agent into vein to assess blood flow of skin graft or flap | 15 | $545 | $36 |
2021: 8 services
| New patient visit (60+ min) | 24 | $4,845 | $202 |
| Short return visit (20+ min) | 40 | $4,205 | $82 |
| New patient visit (45+ min) | 25 | $3,590 | $144 |
| Return visit (30+ min) | 24 | $3,401 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,227 | $92 |
| Long return visit (40+ min) | 11 | $1,996 | $166 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,594 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,104 | $65 |
2020: 6 services
| Diagnostic exam of anus using an endoscope | 18 | $2,064 | $103 |
| Short return visit (20+ min) | 23 | $1,943 | $67 |
| New patient visit (45+ min) | 13 | $1,752 | $135 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,730 | $124 |
| New patient visit (30+ min) | 17 | $1,637 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,413 | $88 |
2019: 9 services
| Diagnostic exam of anus using an endoscope | 27 | $3,061 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $3,021 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $3,018 | $121 |
| New patient visit (60+ min) | 15 | $2,601 | $173 |
| New patient visit (45+ min) | 15 | $2,094 | $140 |
| Long return visit (40+ min) | 13 | $2,021 | $126 |
| Short return visit (20+ min) | 24 | $1,949 | $65 |
| New patient visit (30+ min) | 15 | $1,408 | $94 |
| Short return visit | 11 | $604 | $40 |
Drugs they prescribed that Part D paid
$5,239
Pharmacies billed $5,239 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 33% of their Part D prescriptions (34 of 104) in 2024. Above the middle of the specialty; the typical colorectal surgery (proctology) clinician is at 16%.
103 generic and fewer than 11 brand-name prescriptions · $5,239 in drug cost · 63 antibiotic prescriptions to 32 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ciprofloxacin | 27 | $119 | $4 |
| Metronidazole | 28 | $112 | $4 |
| Oxycodone | 31 | $100 | $3 |
Year by year
| 2024 | 104 | 62 | 33% (34) | None | $5,239 |
| 2023 | 88 | 48 | 16% (14) | 0% | $678 |
| 2022 | 94 | 54 | 20% (19) | None | $1,988 |
| 2021 | 69 | 39 | 25% (17) | None | $552 |
| 2020 | 52 | 24 | 27% (14) | None | $834 |
| 2019 | 87 | 50 | 36% (31) | 0% | $607 |
| 2018 | 23 | 13 | None | 0% | $342 |
| 2017 | 19 | 17 | 79% (15) | None | $148 |
| 2016 | 51 | 43 | 88% (45) | 0% | $724 |
| 2015 | 35 | 29 | 74% (26) | None | $654 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Hydrocortisone | 12 | $213 | $18 |
| Metronidazole | 24 | $38 | $2 |
| Ciprofloxacin | 23 | $27 | $1 |
2022: 3 drugs
| Neomycin Sulfate | 15 | $86 | $6 |
| Hydrocodone-Acetaminophen | 16 | $59 | $4 |
| Metronidazole | 24 | $44 | $2 |
2021: 3 drugs
| Neomycin Sulfate | 19 | $115 | $6 |
| Hydrocodone-Acetaminophen | 15 | $62 | $4 |
| Metronidazole | 21 | $50 | $2 |
2020: 2 drugs
| Neomycin Sulfate | 13 | $84 | $6 |
| Metronidazole | 13 | $44 | $3 |
2019: 3 drugs
| Hydrocodone-Acetaminophen | 23 | $114 | $5 |
| Neomycin Sulfate | 13 | $80 | $6 |
| Metronidazole | 18 | $62 | $3 |
2016: 2 drugs
| Hydrocodone-Acetaminophen | 22 | $372 | $17 |
| Oxycodone | 15 | $196 | $13 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 12 | $128 | $11 |
Money from drug and device companies
$48 in 2025
| 2025 | 2 | 2 | None | $48 |
| 2024 | 2 | 3 | None | $98 |
| 2023 | 1 | 1 | None | $33 |
| 2021 | 1 | 1 | None | $42 |
| 2019 | 2 | 9 | None | $538 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| TELA Bio | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $28 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $20 | 1 payment
|
See all 2 published payments
| TELA Bio | Meals · 2025-09-24 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $28 |
| Intuitive Surgical | Meals · 2025-01-07 | Da Vinci Surgical System | $20 |
See earlier years (2024, 2023, 2021, 2019)
2024: $98
| Teleflex | Titan Sgs | $77 | 2 payments
|
| Ethicon US | Echelon Circular | $21 | 1 payment
|
2023: $33
| Intuitive Surgical | Da Vinci Surgical System | $33 | 1 payment
|
2021: $42
| Davol | Phasix | $42 | 1 payment
|
2019: $538
| Intuitive Surgical | Da Vinci Surgical System | $517 | 8 payments
|
| Prescient Surgical | Cleancision | $21 | 1 payment
|
Professional record
- NPI
- 1184981474
- Licence
- CA A126722California A126722: Current · expires 2026-12-31
- Trained
- Jefferson Medical College of Thomas Jefferson University, 2012
- Group
- Sutter Bay Medical Foundation · County of San Mateo
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Surgery (208600000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2012-04-12
- NPI last updated
- 2020-06-23
- NPI record certified
- 2020-06-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305